ATERHIGH SIGNALRISK10-K

ATER initiated a strategic alternatives process in December 2025 while experiencing substantial operational deterioration and a severe cash position decline.

The Board's decision to explore strategic alternatives—typically code for seeking a buyer or major restructuring—indicates management recognizes the company may not be viable in its current form. The strategic review process triggered immediate impairment testing of brand intangible assets, suggesting potential further write-downs ahead. Combined with the dramatic financial deterioration, this points to a company in distress mode.

Comparing 2026-03-23 vs 2025-03-25View on EDGAR →
FINANCIAL ANALYSIS

ATER's financial position deteriorated markedly, with revenue declining 30% to $69M and cash reserves falling precipitously from $18M to $4.9M. Operating losses widened substantially while gross profit margins compressed significantly. Total assets contracted 40% to $29.6M, reflecting both operational decline and likely asset impairments, painting a picture of a company under severe financial stress.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-73%
$18.0M→$4.9M

Cash declined 73% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Net Income
P&L
-60%
-$11.9M→-$19.0M

Net income declined 60% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-52%
-$11.8M→-$18.0M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Stockholders Equity
Balance Sheet
-49.3%
$30.0M→$15.2M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Total Assets
Balance Sheet
-40.3%
$49.5M→$29.6M

Total assets contracted 40.3% — asset sales, write-downs, or balance sheet optimization underway.

Current Assets
Balance Sheet
-37.8%
$38.7M→$24.1M

Current assets declined 37.8% — monitor working capital adequacy and short-term liquidity.

Gross Profit
P&L
-36.3%
$61.5M→$39.1M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Accounts Receivable
Balance Sheet
-35%
$3.8M→$2.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Revenue
P&L
-30.4%
$99.0M→$69.0M

Revenue declined 30.4% — significant demand weakness or market share loss warrants investigation.

Current Liabilities
Balance Sheet
-26.8%
$19.3M→$14.1M

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-03-23
PRIOR — 2025-03-25
ADDED
The weighted-average remaining amortization period for total intangibles was 5.28 years.
Includes reversal of costs associated with a contract settlement during the year ended December 31, 2024.
In December 2025, the Company announced that its Board of Directors had initiated a process to explore strategic alternatives to maximize shareholder value.
This announcement constituted a triggering event under ASC 350, Intangibles Goodwill and Other, requiring the Company to perform an interim impairment assessment of its definite-lived brand intangible assets.
The Company estimated the fair value of its definite-lived brand assets using market-based inputs, including indicative valuations from market participants obtained during the strategic alternative process.
+7 more — sign up free →
REMOVED
false --12-31 FY 2024 true true true true true false 0.0001 0.0001 500,000,000 500,000,000 7,508,246 8,750,741 2 0.1 3 10 1 1 0 4 3 33.33 66.66 10 1.0 4.1 6,902,816 http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense 0 false false false false See Note 2, Summary of Significant Accounting Policies for more information on intangibles impairments which occurred during the year ended December 31, 2023.
The number of options and exercise price per share have been retroactively restated to reflect the one for twelve (1 for 12) reverse stock split, which was effective on March 22, 2024.
Includes reversal of costs associated with a contract settlement during the three and nine months ended September 30, 2024.
The number of shares and grant date fair value per share have been retroactively restated to reflect the one for twelve (1 for 12) reverse stock split, which was effective on March 22, 2024.
The number of shares and per share amounts have been retroactively restated to reflect the one for twelve (1 for 12) reverse stock split, which was effective on March 22, 2024.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →